Strides Arcolab Ltd (STAR.NS)

STAR.NS on National Stock Exchange of India

665.00INR
2:06pm IST
Price Change (% chg)

Rs5.65 (+0.86%)
Prev Close
Rs659.35
Open
Rs664.40
Day's High
Rs674.50
Day's Low
Rs662.10
Volume
113,331
Avg. Vol
228,209
52-wk High
Rs696.55
52-wk Low
Rs310.15

STAR.NS

Chart for STAR.NS

About

Strides Arcolab Limited (Strides) is a global pharmaceutical company. The Company develops and manufactures a range of intellectual property (IP)-led pharmaceutical products. The Company’s business division includes Pharmaceuticals, Biotech and Specialties (Agila). Agila (Specialties business) is focused on key domains, such as... (more)

Overall

Beta: 1.01
Market Cap (Mil.): Rs39,274.59
Shares Outstanding (Mil.): 59.57
Dividend: 5.00
Yield (%): 0.76

Financials

  STAR.NS Industry Sector
P/E (TTM): 5.44 32.75 33.73
EPS (TTM): 121.15 -- --
ROI: 26.16 18.05 17.35
ROE: 41.93 18.69 18.09
Search Stocks

Indian shares gain for third day; TCS earnings awaited

* NSE ends 0.21 pct higher; BSE index gains 0.04 pct * Crompton Greaves jumps on demerger proposal * Mahindra and Mahindra slumps after block deals * Strides Arcolab gains; Mankekar raises stake to 4.7 pct By Abhishek Vishnoi MUMBAI, July 17 - Indian shares rose for a third straight session on Thursday as lenders such as Kotak Mahindra Bank extended gains on upbeat sentiment as the central bank exempted long-term bonds for the infrastructure sector from reserve req

17 Jul 2014

REFILE-MARKET EYE -India's Strides Arcolab gains; Mankekar raises stake to 4.7 pct

(Corrects typo in company name to Strides from Stride in headline) * Shares in India's Strides Arcolab Ltd gain 2 percent after investor Shivanand Shankar Mankekar raised his stake in the company to 4.7 percent in the June quarter from 1.26 percent held earlier, according to exchange data. * Mankekar increased his share holding in the company via three entities namely, Laxmi Shivanand Mankekar, Shivanand Shankar Mankekar and Kedar Shivanand Mankekar. * Private investor Mankekar is a known stock

17 Jul 2014

Strides surges as Bangalore plant remains U.S. FDA compliant

Reuters Market Eye - Strides Arcolab surges 6.3 percent after the drugmaker said on Friday its oral drug manufacturing facility in Bangalore continues to maintain compliance with the manufacturing standards of the U.S. health regulator.

25 Apr 2014

MARKET EYE -India's Strides surges as Bangalore plant remains U.S. FDA compliant

* India's Strides Arcolab Ltd surges 6.3 percent after the drugmaker said on Friday its oral drug manufacturing facility in Bangalore continues to maintain compliance with the manufacturing standards of the U.S. health regulator. * "U.S. FDA recently inspected this facility as part of GMP compliance audit and raised Form 483 (inspection observations) during the Dec 2013 inspection (which has now been satisfactorily closed)," Macquarie said in a note to its clients. * This is a key positive dev

25 Apr 2014

Earnings vs. Estimates

Search Stocks